Most of the current evidence is from the dermatology field and suggests that 5-ARI users experience a higher rate of depressive symptoms… Urologists prescribing 5-ARIs should be aware of the recent addition of suicide and [suicidal ideation] risk to the list of side effects. A mental health screen should be performed and appropriate resources provided to patients commencing treatment. Furthermore, a review should be arranged with the general practitioner to assess new-onset mental health or SI symptoms.
Al Saffar H, Xu J, O’Brien JS, Kelly BD, Murphy DG, Lawrentschuk N: June 2023 https://doi.org/10.1016/j.euros.2023.04.009. [European Urology Open Science]